KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Angi (ANGI) Cash & Equivalents (2016 - 2025)

Angi's Cash & Equivalents history spans 10 years, with the latest figure at $362.5 million for Q2 2025.

  • For Q2 2025, Cash & Equivalents fell 5.82% year-over-year to $362.5 million; the TTM value through Jun 2025 reached $362.5 million, down 5.82%, while the annual FY2024 figure was $416.4 million, 14.39% up from the prior year.
  • Cash & Equivalents for Q2 2025 was $362.5 million at Angi, down from $386.6 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $777.0 million in Q1 2021 and bottomed at $315.0 million in Q1 2023.
  • The 5-year median for Cash & Equivalents is $377.7 million (2023), against an average of $410.8 million.
  • The largest annual shift saw Cash & Equivalents skyrocketed 102.23% in 2021 before it tumbled 49.64% in 2022.
  • A 5-year view of Cash & Equivalents shows it stood at $428.1 million in 2021, then dropped by 24.99% to $321.2 million in 2022, then rose by 13.35% to $364.0 million in 2023, then rose by 14.39% to $416.4 million in 2024, then decreased by 12.96% to $362.5 million in 2025.
  • Per Business Quant, the three most recent readings for ANGI's Cash & Equivalents are $362.5 million (Q2 2025), $386.6 million (Q1 2025), and $416.4 million (Q4 2024).